Penumbra’s POD (Penumbra Occlusion Device) packing coil for the embolization of peripheral vessels and aneurysms adds to its growing peripheral vascular business, which includes the Indigo mechanical thrombectomy system, POD and Ruby embolization coil.
Penumbra has announced the US launch of its new POD packing coil, designed to be used as a complementary device with Penumbra’s Ruby and POD embolization products. The new POD packing coil is designed to pack very densely behind Ruby and POD to occlude arteries and veins throughout the peripheral vasculature, including aneurysms.
Penumbra’s Indigo system is a continuous aspiration thrombectomy device designed to remove fresh, soft emboli and thrombi from the peripheral arteries and veins. The aspiration lumen is paired with a proprietary continuous vacuum aspiration pump to evacuate clot effectively and efficiently.
“With the Indigo System and POD, Penumbra has recently introduced products that have had significant impact on the treatment of vascular disease. Indigo represents a significant advancement in the treatment of thrombotic and embolic disease, which until now has had limited treatment options,” said Corey Teigen, Sanford Health, Fargo, USA, who uses Penumbra’s peripheral vascular products. “With the Indigo system, physicians now have the ability to remove limb- and life-threatening clots quickly and efficiently. Likewise the POD, Ruby and now the POD packing coil optimise embolization procedures by decreasing procedure time while providing increased control.”
“Our embolization platform and the Indigo System are examples of our commitment to innovating new technologies for challenging vascular conditions for which there are significant unmet clinical needs,” said Adam Elsesser, chairman and CEO of Penumbra. “We are intent on changing treatment paradigms to improve clinical outcomes across two large and growing markets: neuro and peripheral vascular.”
